Vernon Hills, IL, United States of America

Michael D Wendt

This inventor holds 48 USPTO granted patents and 42 published patent applications, plus 8 CIPO patents and 19 EPO patents, primarily in Cancer Therapeutics. Top assignees: Abbvie Inc., Abbott Laboratories Corporation, Walter and Eliza Hall Institute of Medical Research. Active years: 1997-2024.

USPTO Granted Patents = 48 (Patent Applications = 42)

% Patents Active = 87.5

CIPO Patents = 8 (Patent Applications = 11)

EPO Patents = 19 (Patent Applications = 32)

Average Co-Inventor Count = 10.2

ph-index = 19

Forward Citations = 1,028(Granted Patents)

Location History:

North Chicago, IL (US) (1997 - 2001)
Deerfield, IL (US) (2001)
Vernon Hills, IL (US) (2002 - 2024)

Company Filing History:

Abbott Laboratories Corporation

patents

3 out of 84

Walter and Eliza Hall Institute of Medical Research

5. 1 out of 834,307

Other

patents

where one patent can have more than one assignee

Years Active: 1997-2024

Loading Chart...

Areas of Expertise:

Apoptosis Inducing Agents

Cancer Treatment

Immune Diseases

Bcl-2 Inhibitors

Macrocyclic Inhibitors

Apoptosis Promoters

Pyridinone Derivatives

Survivin Inhibitors

Biaryl Carboxylic Acids

N-acylsulfonamide

Autoimmune Diseases

48 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11897864 - Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases (2024-02-13),

2. 11786519 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases (2023-10-17),

3. 10676485 - Macrocyclic MCL-1 inhibitors and methods of use (2020-06-09),

4. 10081628 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases (2018-09-25),

5. 9877958 - Apoptosis-induced agents for the treatment of cancer and immune and autoimmune diseases (2018-01-30),

6. 9844547 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases (2017-12-19),

7. 9561231 - Pyridinone and pyridazinone derivatives (2017-02-07),

8. 9315488 - Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases (2016-04-19),

9. 9303025 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases (2016-04-05),

10. 9266877 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases (2016-02-23),

11. 9227963 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases (2016-01-05),

12. 9174982 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases (2015-11-03),

13. 9156856 - Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases (2015-10-13),

14. 9125913 - Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases (2015-09-08),

15. 9073855 - BCL-2 selective apoptosis-inducing agents for the treatment of cancer and immune diseases (2015-07-07),

Title: Inventor Michael D Wendt - Pioneering Innovations in Vernon Hills

Introduction: Michael D Wendt is a distinguished inventor based in Vernon Hills, Illinois, known for his groundbreaking contributions to various industries.

Latest Patents: Michael D Wendt holds several patents in the fields of technology, healthcare, and consumer products, showcasing his versatility and ingenuity.

Career Highlights: With a career spanning over two decades, Michael D Wendt has consistently demonstrated a keen ability to identify gaps in the market and develop innovative solutions to address them.

Collaborations: Throughout his career, Michael D Wendt has collaborated with leading companies, research institutions, and universities to bring his inventions to life, further solidifying his reputation as a visionary inventor.

Conclusion: Michael D Wendt's passion for innovation and his relentless drive to push the boundaries of what is possible make him a true pioneer in the world of inventions.